A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

Summary

A multicenter, randomized, double-blind, placebo-controlled clinical trial was designed. A total of 120 subjects were randomly assigned to two experimental groups (lowe-dose ZKY001 eye drops group,Medium-dose ZKY001 eye drops group) and a placebo control group, with 40 subjects in each group.

Timeline

Start

2022-08-03

Primary completion

2022-11-08

Completion

2022-11-08

Drugs

Indications